CD40LG and infection: Moreover, we observed a decreasing trend in the percentage of ZIKV-positive women with detectable ZIKV-specific IgM antibodies over the 12 months after infection, peaking at 8.1% 1 to 2-months after symptom onset and declining to 1.1% by 4 to 5-months after symptom onset.